Repurposing of Thalidomide as a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study. Int. J. Res. Pharm. Sci. Technol. 2026;9(3). doi:10.33974/st7x9s50